Enter inventor name

Inigo Saenz De Tejada

USPTO Granted Patents = 32 (Patent Applications = 1)

Average Co-Inventor Count = 2.3

ph-index = 14

Forward Citations = 429(Granted Patents)

Company Filing History:

The Brigham and Women's Hospital, Inc.

where one patent can have more than one assignee

Years Active: 1997-2010

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7772278 - Nitrosated and nitrosylated prostaglandins, compositions and methods of use (2010-08-10),

2. 7449595 - Nitrosated and nitrosylated prostaglandins, compositions and methods of use (2008-11-11),

3. 7176238 - Nitrostated and nitrosylated prostaglandins, compositions and methods of use (2007-02-13),

4. 6930113 - Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use (2005-08-16),

5. 6693122 - Nitrosated and nitrosylated potassium channel activators, compositions and methods of use (2004-02-17),

6. 6514934 - Imidazoline &agr;-adrenergic receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use (2003-02-04),

7. 6472425 - Methods for treating female sexual dysfunctions (2002-10-29),

8. 6462044 - Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use (2002-10-08),

9. 6436997 - Endogenous nitric oxide synthesis under conditions of low oxygen tension (2002-08-20),

10. 6433182 - Nitrosated and nitrosylated &agr;-adrenergic receptor antagonist compounds, compositions and their uses (2002-08-13),

11. 6417207 - Nitrosated and nitrosylated potassium channel activators, compositions and methods of use (2002-07-09),

12. 6417162 - Nitrosated and nitrosylated &agr;-adrenergic receptor antagonist compounds, compositions and their uses (2002-07-09),

13. 6331543 - Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use (2001-12-18),

14. 6323211 - Compositions and methods for treating sexual dysfunctions (2001-11-27),

15. 6316457 - Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses (2001-11-13),

Title: Inigo Saenz de Tejada: Innovator in Prostaglandin Research

Introduction

Inigo Saenz de Tejada is a distinguished inventor based in Madrid, Spain, known for his significant contributions to the field of prostaglandin research. With a remarkable portfolio of 32 patents, Saenz de Tejada has made groundbreaking advancements that hold the potential to revolutionize treatments for various medical conditions.

Latest Patents

One of his latest inventions is the development of nitrosated and nitrosylated prostaglandins with novel compositions. This invention describes the application of these compounds, particularly referring to a composition that includes at least one nitrosated or nitrosylated prostaglandin and a compound that can donate or release nitric oxide. This innovative combination aims to elevate the levels of endothelium-derived relaxing factors, stimulate the synthesis of nitric oxide, and reduce instances of various disorders. The patent also delineates methods for addressing sexual dysfunction in both males and females, enhancing sexual responses, and treating conditions such as cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia (BPH), glaucoma, peptic ulcers, and for inducing abortions.

Career Highlights

Saenz de Tejada has garnered considerable recognition in the medical research community through his work at prominent institutions. He has played integral roles at Nitromed, Inc. and The Brigham and Women's Hospital, Inc., where his research and innovations have paved the way for new therapeutic options.

Collaborations

Throughout his career, Saenz de Tejada has collaborated with esteemed colleagues such as David S. Garvey and Joseph David Schroeder. These partnerships have fostered an environment of innovation and have been crucial to his development of new treatments and research methodologies.

Conclusion

Inigo Saenz de Tejada stands out as a pioneering inventor in the medical field, particularly within prostaglandin research. His extensive patent portfolio reflects his commitment to advancing medical therapies that improve patient care and outcomes. Through his innovative work and collaborations, Saenz de Tejada continues to make significant strides in addressing complex health issues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com